Leukapheresis Products Market Research Report: By Type (Leukapheresis Devices, Leukapheresis Disposables), Application (Research Applications, Therapeutic Applications), End User (Blood Component Provider and Blood Center, Other) -Forecast Till 2027
ID: MRFR/MED/5303-HCR | February 2021 | Region: Global | 90 pages
Leukapheresis Products Market Scenario:
Leukapheresis products market is expected to grow significantly over the forecast period. Leukapheresis products market is anticipated that the market held a market value of USD 19.2 million in 2017 and is projected to grow at a CAGR of 7.7% over the forecast period.
Leukapheresis is a procedure of removing abnormal white blood cells (WBCs) from the blood. Leukapheresis can be used as a treatment for certain types of leukemia or as the first step of chimeric antigen receptor (CAR) T-cell therapy. The growing number of blood donations, increasing prevalence of leukaemia, and demand for leukapheresis products in clinical research are some factors that are anticipated to propel the growth of the market. According to the Facts and Figures 2017-2018 by the Leukemia and Lymphoma Society, an estimated 1,345,123 people in the US are living with or in remission from leukemia, lymphoma or myeloma. On the other hand, the high cost of therapeutic leukapheresis, dearth of skilled professionals, and stringent donor recruitment criteria may hinder the market growth over the forecast period.
Segmentation:
The leukapheresis products market has been segmented into type, application, and end user. On the basis of type, the market has been segmented into leukapheresis devices and leukapheresis disposables. The leukapheresis devices segment has been segmented into apheresis devices, leukapheresis column & cell separators, and leukoreduction filters.
The market, on the basis of application, has been segmented into research applications and therapeutic applications.
On the basis of end user, the market has been segmented into blood component providers and blood centers, hospitals and transfusion centers, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The leukapheresis products market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European leukapheresis products market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The leukapheresis products market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The leukapheresis products market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key players:
Haemonetics, Terumo BCT, Asahi Kasei Medical, STEMCELL Technologies, Macopharma, HemaCare Corporation, Caltag Medsystem, ALLCells, LLC, ZENBIO, Fresenius Kabi, PPA Research Group, StemExpress and others are some of the key players in the leukapheresis products market.
Regional Market Summary:
Global Leukapheresis Products Market Share (%), by Region, 2017 
Source: America’s Blood Centers, White Papers, Company Presentations, Annual Reports
Geographically, the Americas is anticipated to dominate the leukapheresis products market owing to the growing number of blood donations, rising incidence and prevalence of leukaemia and growing demand for leukopaks in clinical research. According to the America’s Blood Centers, more than 15 million pints of blood are transfused in the US each year.
Europe is expected to hold the second largest position in the leukapheresis products market. The market growth in this region is attributed to the increasing prevalence of leukemia and well-developed healthcare sector in the region. According to the Cancer Research UK, about 9,900 new cases of leukaemia were reported in UK in 2015.
The leukapheresis products market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the increasing presence of major multinational pharma and biotech companies, and improvement in healthcare access.
The Middle East & Africa has the lowest share of the leukapheresis products market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.
Leukapheresis Products Market, by Type
- Leukapheresis Devices
- Apheresis Devices
- Leukapheresis Columns & Cell Separators
- Leukoreduction Filters
- Leukapheresis Disposables
Leukapheresis Products Market, by Application
- Research Applications
- Therapeutic Applications
Leukapheresis Products Market, by End User
- Blood Component Providers and Blood Centers
- Hospitals and Transfusion Centers
- Others
Leukapheresis Products Market, by Region
- Americas
- North America
- US
- Canada
- South America
- North America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- The Middle East & Africa
- Middle East
- Africa
Leukapheresis Products Market, by Key Players
- Haemonetics
- Terumo BCT
- Asahi Kasei Medical
- STEMCELL Technologies
- Macopharma
- Caltag Medsystem
- ZENBIO
- Fresenius Kabi
- PPA Research Group
- StemExpress
- HemaCare Corporation
- ALLCells, LLC
- Others
Intended Audience
- Apheresis Device Manufacturers and Distributors
- Leukapheresis Product Manufacturers and Distributors
- Pharmaceutical and Biotechnological Companies
- Healthcare Service Providers (including Hospitals and Transfusion Centers)
- Cancer Treatment Centers
- Blood Component Providers & Blood Centers
- Contract Research Organizations
- Academic and Research Institutes
- Government Associations
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size |
|
| CAGR | 7.7% (2017-2023) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Application and End user |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Haemonetics, Terumo BCT, Asahi Kasei Medical, STEMCELL Technologies, Macopharma, HemaCare Corporation, Caltag Medsystem, ALLCells, LLC, ZENBIO, Fresenius Kabi, PPA Research Group, StemExpress and others |
| Key Market Opportunities | New product launches and R&D Amongst major key Players |
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
The leukapheresis products market is projected to grow at a 7.7% CAGR between 2018-2023.
The Americas is projected to command the largest share in the leukapheresis products market.
Rising prevalence of leukemia is boosting market growth.
High cost may limit market growth.
Different strategies used by market players to create a dominance in the leukapheresis products market include product launches, collaborations, strategic alliances, and others.
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Leukapheresis Products Market, by Type
6.1 Introduction
6.2 Leukapheresis Devices
6.2.1 Apheresis Devices
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.2 Leukapheresis Columns & Cell Separators
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.3 Leukoreduction Filters
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3 Leukapheresis Disposables
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 7. Global Leukapheresis Products Market, by Application
7.1 Introduction
7.2 Research Applications
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3 Therapeutic Applications
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 8. Global Leukapheresis Products Market, by End User
8.1 Introduction
8.2 Blood Component Providers and Blood Centers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3 Hospitals and Transfusion Centers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.4 Others
Chapter 9. Global Leukapheresis Products Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 Haemonetics
11.1.1 Company Overview
11.1.2 Treatment Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Terumo BCT
11.2.1 Company Overview
11.2.2 Treatment Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Asahi Kasei Medical
11.3.1 Company Overview
11.3.2 Treatment Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 STEMCELL Technologies
11.4.1 Company Overview
11.4.2 Treatment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Macopharma
11.5.1 Company Overview
11.5.2 Treatment Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Caltag Medsystem
11.6.1 Company Overview
11.6.2 Treatment Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 ZENBIO
11.7.1 Overview
11.7.2 Treatment Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Fresenius Kabi
11.8.1 Overview
11.8.2 Treatment Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 PPA Research Group
11.9.1 Overview
11.9.2 Treatment Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 StemExpress
11.10.1 Overview
11.10.2 Treatment Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 HemaCare Corporation
11.11.1 Overview
11.11.2 Treatment Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 ALLCells, LLC
11.12.1 Overview
11.12.2 Treatment Overview
11.12.3 Financials
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.13 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
13.1.1 From CEO’s View point
13.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the Leukapheresis Products Industry
Chapter 13. Appendix
LIST OF TABLES
Table 1 Global Leukapheresis Products Market Synopsis, 2020-2027
Table 2 Global Leukapheresis Products Market Estimates and Forecast, 2020-2027
(USD Million)
Table 3 Global Leukapheresis Products Market, by Region, 2020-2027 (USD Million)
Table 4 Global Leukapheresis Products Market, by Type, 2020-2027 (USD Million)
Table 5 Global Leukapheresis Products Market, by Application, 2020-2027 (USD Million)
Table 6 Global Leukapheresis Products Market, by End User, 2020-2027 (USD Million)
Table 7 North America: Leukapheresis Products Market, by Type, 2020-2027 (USD Million)
Table 8 North America: Leukapheresis Products Market, by Application, 2020-2027 (USD Million)
Table 9 North America: Leukapheresis Products Market, by End User, 2020-2027 (USD Million)
Table 10 US: Leukapheresis Products Market, by Type, 2020-2027 (USD Million)
Table 11 US: Leukapheresis Products Market, by Application, 2020-2027 (USD Million)
Table 12 US: Leukapheresis Products Market, by End User, 2020-2027 (USD Million)
Table 13 Canada: Leukapheresis Products Market,by Type, 2020-2027 (USD Million)
Table 14 Canada: Leukapheresis Products Market,by Application, 2020-2027 (USD Million)
Table 15 Canada: Leukapheresis Products Market, by End User, 2020-2027 (USD Million)
Table 16 South America: Leukapheresis Products Market, by Type, 2020-2027 (USD Million)
Table 17 South America: Leukapheresis Products Market, by Application, 2020-2027 (USD
Million)
Table 18 South America: Leukapheresis Products Market, by End User, 2020-2027 (USD Million)
Table 19 Europe: Leukapheresis Products Market, by Type, 2020-2027 (USD Million)
Table 20 Europe: Leukapheresis Products Market, by Application, 2020-2027 (USD Million)
Table 21 Europe: Leukapheresis Products Market, by End User, 2020-2027 (USD Million)
Table 22 Western Europe: Leukapheresis Products Market, by Type, 2020-2027 (USD Million)
Table 23 Western Europe: Leukapheresis Products Market, by Application, 2020-2027 (USD
Million)
Table 24 Western Europe: Leukapheresis Products Market, by End User, 2020-2027 (USD
Million)
Table 25 Eastern Europe: Leukapheresis Products Market, by Type, 2020-2027 (USD Million)
Table 26 Eastern Europe: Leukapheresis Products Market, by Application, 2020-2027 (USD
Million)
Table 27 Eastern Europe: Leukapheresis Products Market, by End User, 2020-2027 (USD
Million)
Table 28 Asia-Pacific: Leukapheresis Products Market, by Type, 2020-2027 (USD Million)
Table 30 Asia-Pacific: Leukapheresis Products Market, by Application, 2020-2027 (USD Million)
Table 31 Asia-Pacific: Leukapheresis Products Market, by End User, 2020-2027 (USD
Million)
Table 32 Middle East & Africa: Leukapheresis Products Market, by Type, 2020-2027 (USD
Million)
Table 33 Middle East & Africa: Leukapheresis Products Market, by Application, 2020-2027 (USD
Million)
Table 34 Middle East & Africa: Leukapheresis Products Market, by End User, 2020-2027 (USD
Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Leukapheresis Products Market
Figure 3 Segmentation Market Dynamics for Global Leukapheresis Products Market
Figure 4 Global Leukapheresis Products Market Share, by Type, 2020
Figure 5 Global Leukapheresis Products Market Share, by Application, 2020
Figure 6 Global Leukapheresis Products Market Share, by End User, 2020
Figure 7 Global Leukapheresis Products Market Share, by Region, 2020
Figure 8 North America: Leukapheresis Products Market Share, by Country, 2020
Figure 9 Europe: Leukapheresis Products Market Share, by Country, 2020
Figure 10 Asia-Pacific: Leukapheresis Products Market Share, by Country, 2020
Figure 11 Middle East & Africa: Leukapheresis Products Market Share, by Country, 201
Figure 12 Global Leukapheresis Products Market: Company Share Analysis, 2020 (%)
Figure 13 Haemonetics: Key Financials
Figure 14 Haemonetics: Segmental Revenue
Figure 15 Haemonetics: Geographical Revenue
Figure 16 Terumo BCT: Key Financials
Figure 17 Terumo BCT: Segmental Revenue
Figure 18 Terumo BCT: Geographical Revenue
Figure 19 Asahi Kasei Medical: Key Financials
Figure 20 Asahi Kasei Medical: Segmental Revenue
Figure 21 Asahi Kasei Medical: Geographical Revenue
Figure 22 STEMCELL Technologies : Key Financials
Figure 23 STEMCELL Technologies: Segmental Revenue
Figure 24 STEMCELL Technologies : Geographical Revenue
Figure 25 Macopharma: Key Financials
Figure 26 Macopharma: Segmental Revenue
Figure 27 Macopharma: Geographical Revenue
Figure 28 Caltag Medsystem: Key Financials
Figure 29 Caltag Medsystem: Segmental Revenue
Figure 30 Caltag Medsystem: Geographical Revenue
Figure 31 ZENBIO: Key Financials
Figure 32 ZENBIO: Segmental Revenue
Figure 33 ZENBIO: Geographical Revenue
Figure 34 Fresenius Kabi: Key Financials
Figure 35 Fresenius Kabi: Segmental Revenue
Figure 36 Fresenius Kabi: Geographical Revenue
Figure 37 PPA Research Group: Key Financials
Figure 38 PPA Research Group: Segmental Revenue
Figure 39 PPA Research Group: Geographical Revenue
Figure 40 StemExpress: Key Financials
Figure 41 StemExpress : Segmental Revenue
Figure 42 StemExpress: Geographical Revenue
Figure 43 HemaCare Corporation: Key Financials
Figure 44 HemaCare Corporation: Segmental Revenue
Figure 45 HemaCare Corporation: Geographical Revenue
Figure 46 ALLCells, LLC: Key Financials
Figure 47 ALLCells, LLC: Segmental Revenue
Figure 48 ALLCells, LLC: Geographical Revenue